| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035078161 |
| P356 | DOI | 10.1208/AAPSJ080362 |
| P932 | PMC publication ID | 2761060 |
| P698 | PubMed publication ID | 17025271 |
| P5875 | ResearchGate publication ID | 6770327 |
| P2093 | author name string | Hazel H Szeto | |
| P2860 | cites work | Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in PC-12 cells | Q24293297 |
| Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
| Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools | Q28241521 | ||
| Oxidative stress in neurodegeneration: cause or consequence? | Q28275946 | ||
| Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis | Q28283313 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| Complex III releases superoxide to both sides of the inner mitochondrial membrane | Q28509539 | ||
| A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase | Q28510284 | ||
| Cytochrome c release from mitochondria proceeds by a two-step process | Q28571562 | ||
| Mitochondrial dysfunction and oxidative damage in parkin-deficient mice | Q28593859 | ||
| Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport | Q28594710 | ||
| Mitochondria and apoptosis | Q29547905 | ||
| The mitochondrial permeability transition pore and its role in cell death | Q29614183 | ||
| Mitochondrial free radical generation, oxidative stress, and aging | Q29614202 | ||
| Extension of murine life span by overexpression of catalase targeted to mitochondria | Q29614546 | ||
| Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants | Q29615627 | ||
| Selective targeting of an antioxidant to mitochondria | Q30581066 | ||
| Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis | Q30777447 | ||
| Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides | Q31121431 | ||
| In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. | Q31136237 | ||
| Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties | Q31621261 | ||
| Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia | Q33540916 | ||
| Drug delivery to mitochondria: the key to mitochondrial medicine | Q33853014 | ||
| Mitochondria, oxidative damage, and inflammation in Parkinson's disease | Q34212155 | ||
| The energetics of Huntington's disease | Q34308028 | ||
| Pharmacologic treatment of the stunned myocardium: the concepts and the challenges | Q34329617 | ||
| The mitochondrial death/life regulator in apoptosis and necrosis | Q34465435 | ||
| Superoxide dismutase and the death of motoneurons in ALS. | Q34553806 | ||
| Oxidatively modified proteins in aging and disease | Q34615830 | ||
| The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases | Q34679230 | ||
| Delivery of bioactive molecules to mitochondria in vivo. | Q34983135 | ||
| Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo | Q35044475 | ||
| Cell-permeable, mitochondrial-targeted, peptide antioxidants | Q35594854 | ||
| Mitochondrial enzyme activities as biochemical markers of aging | Q35722427 | ||
| Catalytic antioxidants: a radical approach to new therapeutics | Q35808784 | ||
| Mitochondrial metabolism of reactive oxygen species. | Q36088215 | ||
| Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation | Q36114650 | ||
| Mitochondria take center stage in aging and neurodegeneration | Q36264218 | ||
| Targeting antioxidants to mitochondria: a new therapeutic direction | Q36341069 | ||
| Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication | Q36986848 | ||
| Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines | Q40363556 | ||
| Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease | Q40411589 | ||
| Mitochondria permeability transition-dependent tert-butyl hydroperoxide-induced apoptosis in hepatoma HepG2 cells | Q40593167 | ||
| Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration | Q40631358 | ||
| Superoxide production by the mitochondrial respiratory chain | Q41488866 | ||
| Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. | Q42632235 | ||
| Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides | Q42806258 | ||
| In vivo pharmacokinetics of selective mu-opioid peptide agonists | Q43641850 | ||
| Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. | Q43653393 | ||
| The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal | Q43683788 | ||
| Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration | Q43735211 | ||
| Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors | Q44028888 | ||
| A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning | Q44068518 | ||
| Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide | Q44255029 | ||
| Studies on the internalization mechanism of cationic cell-penetrating peptides. | Q44463875 | ||
| Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. | Q44552037 | ||
| Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria | Q44680963 | ||
| Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury | Q44922430 | ||
| Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis | Q44954085 | ||
| Mechanism of tert-butylhydroperoxide induced apoptosis in rat hepatocytes: involvement of mitochondria and endoplasmic reticulum | Q45712649 | ||
| Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons | Q46217083 | ||
| Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. | Q46590824 | ||
| A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats | Q46666228 | ||
| Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis | Q46805732 | ||
| ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease | Q47754186 | ||
| Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. | Q48975079 | ||
| Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. | Q49134222 | ||
| Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. | Q51714635 | ||
| Modulation of membrane phospholipid fatty acid composition by age and food restriction | Q70578417 | ||
| Alterations in mitochondrial membrane fluidity by lipid peroxidation products | Q72461830 | ||
| Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation | Q73101546 | ||
| Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species | Q73322667 | ||
| Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases | Q73614293 | ||
| Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model | Q73852676 | ||
| Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues | Q74248716 | ||
| Contribution of increased mitochondrial free Ca2+ to the mitochondrial permeability transition induced by tert-butylhydroperoxide in rat hepatocytes | Q77363690 | ||
| Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis | Q80076165 | ||
| Potent mitochondria-targeted peptides reduce myocardial infarction in rats | Q80147610 | ||
| Are mitochondria critical in the pathogenesis of Alzheimer's disease? | Q81440649 | ||
| Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury | Q81901994 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E521-31 | |
| P577 | publication date | 2006-08-18 | |
| P1433 | published in | The AAPS Journal | Q10695361 |
| P1476 | title | Mitochondria-targeted peptide antioxidants: novel neuroprotective agents | |
| P478 | volume | 8 |
| Q47655433 | A mitochondrial-targeted antioxidant improves myofilament Ca2+ sensitivity during prolonged low frequency force depression at low PO2. |
| Q36977395 | A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction |
| Q39644136 | A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP+-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling |
| Q35737647 | Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics |
| Q28573969 | Acute and/or chronic stress models modulate CuZnSOD and MnSOD protein expression in rat liver |
| Q37835047 | Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects |
| Q41945324 | Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease |
| Q34800195 | An overview on the correlation of neurological disorders with cardiovascular disease |
| Q42180667 | Antioxidant strategies in the management of diabetic neuropathy. |
| Q35126945 | Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage |
| Q51300610 | Astaxanthin modulates age-associated mitochondrial dysfunction in healthy dogs. |
| Q37607012 | Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. |
| Q41200346 | Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells. |
| Q39162782 | Boosting antioxidants by lipophilization: a strategy to increase cell uptake and target mitochondria |
| Q34415748 | Burn trauma in skeletal muscle results in oxidative stress as assessed by in vivo electron paramagnetic resonance. |
| Q47547640 | Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. |
| Q30437957 | Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain |
| Q46761200 | Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros-mediated remodeling |
| Q85238223 | Changes of mitochondrial ultrastructures and function in central nervous tissue of hens treated with tri-ortho-cresyl phosphate (TOCP) |
| Q64965433 | Cocaine‑ and amphetamine‑regulated transcript (CART) is associated with dopamine and is protective against ischemic stroke. |
| Q99579035 | Composite ammonium glycyrrhizin has hepatoprotective effects in chicken hepatocytes with lipopolysaccharide/enrofloxacin-induced injury |
| Q38120531 | Deconstructing mitochondrial dysfunction in Alzheimer disease |
| Q38315902 | Delivery aspects of antioxidants in diabetes management |
| Q41327195 | Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity |
| Q34365603 | Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke |
| Q28300234 | Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases |
| Q46573928 | Effects of N-acetylcysteine on isolated mouse skeletal muscle: contractile properties, temperature dependence, and metabolism |
| Q28576031 | Efflux of iron from the cerebrospinal fluid to the blood at the blood-CSF barrier: effect of manganese exposure |
| Q39722617 | Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance. |
| Q90395794 | Gelidium amansii Attenuates Hypoxia/Reoxygenation-Induced Oxidative Injury in Primary Hippocampal Neurons through Suppressing GluN2B Expression |
| Q91950831 | HSP90 inhibitor 17AAG attenuates sevoflurane-induced neurotoxicity in rats and human neuroglioma cells via induction of HSP70 |
| Q27005955 | Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies |
| Q61443649 | High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich ascites |
| Q26766040 | Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration |
| Q37357130 | Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats |
| Q43083626 | In vivo high-resolution magic angle spinning magnetic and electron paramagnetic resonance spectroscopic analysis of mitochondria-targeted peptide in Drosophila melanogaster with trauma-induced thoracic injury |
| Q47642557 | Interplay between ROS and Antioxidants during Ischemia-Reperfusion Injuries in Cardiac and Skeletal Muscle |
| Q26767093 | Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease |
| Q28397133 | Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies |
| Q92671714 | Iron and oxidizing species in oxidative stress and Alzheimer's disease |
| Q48647754 | Mechanisms of TiO2 nanoparticle-induced neuronal apoptosis in rat primary cultured hippocampal neurons |
| Q39537997 | Melatonin treatment following stroke induction modulates L-arginine metabolism. |
| Q37776434 | Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction |
| Q28382780 | Mitochondria as a target in treatment |
| Q64245244 | Mitochondria-Responsive Drug Release along with Heat Shock Mediated by Multifunctional Glycolipid Micelles for Precise Cancer Chemo-Phototherapy |
| Q36441971 | Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease |
| Q26744639 | Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury |
| Q26859141 | Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases |
| Q39400621 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. |
| Q48314660 | Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease. |
| Q37466059 | Mitochondria: a therapeutic target in neurodegeneration |
| Q46852259 | Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis |
| Q34731547 | Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics |
| Q35806752 | Mitochondrial Dysfunction during Brain Aging: Role of Oxidative Stress and Modulation by Antioxidant Supplementation. |
| Q42247172 | Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans |
| Q33290978 | Mitochondrial mechanism of neuroprotection by CART |
| Q38103249 | Mitochondrial mechanisms of neuroglobin's neuroprotection |
| Q35606693 | Mitochondrial medicine for aging and neurodegenerative diseases |
| Q36358060 | Mitochondrial medicine: pharmacological targeting of mitochondria in disease |
| Q34988040 | Mitochondrial pharmacology: electron transport chain bypass as strategies to treat mitochondrial dysfunction |
| Q54597053 | Mitochondrial production of reactive oxygen species contributes to the β-adrenergic stimulation of mouse cardiomycytes. |
| Q37799814 | Mitochondrial protein tyrosine nitration |
| Q35645530 | Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases |
| Q35532937 | Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation |
| Q64936734 | Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway. |
| Q37682674 | Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency. |
| Q30565636 | Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration |
| Q38165639 | Nanopreparations for organelle-specific delivery in cancer |
| Q33614346 | Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. |
| Q26778823 | Neuropharmacological Potential of Gastrodia elata Blume and Its Components |
| Q50508432 | Neuroprotective effects of anthocyanins on apoptosis induced by mitochondrial oxidative stress. |
| Q39517711 | Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. |
| Q26765483 | New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity |
| Q31135310 | Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound |
| Q50574554 | Oxidative stress and antioxidant status of pregnant rural women in north-west Nigeria: prospective cohort study. |
| Q34094532 | Oxidative stress, mitochondrial damage and neurodegenerative diseases |
| Q35112580 | PEP-1-SOD1 protects brain from ischemic insult following asphyxial cardiac arrest in rats |
| Q39008879 | Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides |
| Q37934984 | Polyphenols and human health: a prospectus. |
| Q37168753 | Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies |
| Q34117168 | Potential therapeutic benefits of strategies directed to mitochondria. |
| Q41680998 | Proapoptotic activity of aflatoxin B1 and sterigmatocystin in HepG2 cells |
| Q34043194 | Profiling of oxidative stress in patients with inborn errors of metabolism |
| Q92702793 | Pros and Cons of Use of Mitochondria-Targeted Antioxidants |
| Q48474348 | Protective effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression |
| Q37720064 | Protective effect of mitochondria‑targeted peptide MTP‑131 against oxidative stress‑induced apoptosis in RGC‑5 cells |
| Q43277890 | Protective effect of serotonin derivatives on glucose-induced damage in PC12 rat pheochromocytoma cells |
| Q34259416 | Protective effects of Lycium barbarum polysaccharide on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion |
| Q35688955 | Protective effects of SS31 on t‑BHP induced oxidative damage in 661W cells |
| Q30539499 | Quantitative analysis of axonal transport by using compartmentalized and surface micropatterned culture of neurons. |
| Q24654614 | Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy |
| Q28388989 | Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling |
| Q42376408 | Regulation of exercise blood flow: Role of free radicals |
| Q34308687 | Review: Mitochondria and disease progression in multiple sclerosis |
| Q59799223 | Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis |
| Q38487545 | Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. |
| Q33719128 | Silybum marianum oil attenuates oxidative stress and ameliorates mitochondrial dysfunction in mice treated with D-galactose |
| Q64776535 | Small molecules as therapeutic drugs for Alzheimer's disease |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q38253060 | Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants. |
| Q37161062 | Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress |
| Q35898625 | Synaptic mitochondrial pathology in Alzheimer's disease |
| Q48513067 | Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease |
| Q40007894 | Synthesis of 3-(1-Methyl-1H-imidazol-2-ylthio)propanoic Acid and (E)-3-(1-Methyl-1H-imidazol-2-ylthio)acrylic Acid |
| Q33972592 | Targeted delivery of radioprotective agents to mitochondria |
| Q98564794 | Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia |
| Q34309756 | Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease |
| Q90568414 | The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury |
| Q38841508 | The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained |
| Q37441183 | The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? |
| Q38071901 | The holistic 3M modality of drug delivery nanosystems for cancer therapy |
| Q90109328 | The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice |
| Q46966271 | The role of mitochondrial and oxidative injury in BDE 47 toxicity to human fetal liver hematopoietic stem cells |
| Q35735828 | TiO2 nanoparticles-induced apoptosis of primary cultured Sertoli cells of mice |
| Q34566188 | Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31. |
| Q52727751 | Triphenylphosphonium Moiety Modulates Proteolytic Stability and Potentiates Neuroprotective Activity of Antioxidant Tetrapeptides in Vitro. |
| Q38196788 | Visualization and quantification of neurochemicals with gold nanoparticles: opportunities and challenges. |
| Q48368069 | Window of opportunity for neuroprotection with an antioxidant, allene oxide synthase, after hypoxia-ischemia in adult male rats. |
Search more.